| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |